Infectious Disease

Top Story

START: Early ART benefits all HIV-positive adults

July 27, 2015

The immediate initiation of ART in asymptomatic HIV-positive adults with a CD4+ count of more than 500 cells/mm3 significantly reduced rates of serious AIDS-related and non-AIDS–related events, according to recent findings from the Strategic Timing of Antiretroviral Treatment, or START, trial.

“The results show that early treatment not only reduces opportunistic infections, which offers a bigger benefit in lower-income countries, but it also prevents a significant amount of illness in higher-income countries as well by reducing the risk of serious non-AIDS events that consisted largely of cancer and cardiovascular disease,” Jens D. Lundgren, MD, chief physician and director of the Copenhagen HIV Program in Denmark and co-chair of the START trial, said in a press release.

EMA approves use of Mosquirix for malaria prevention among sub-Saharan African children

July 27, 2015
The Committee for Medicinal Products for Human Use of the European Medicines Agency recently adopted a positive scientific opinion for the malaria candidate vaccine…
In the Journals

Opioid tampering by providers who use drugs increases risk for HCV transmission

July 27, 2015
Health care providers with unknown hepatitis C virus infection who injected drugs had a high risk for contributing to nosocomial outbreaks of the infection due to…
In the Journals

Ethanol locks reduce central venous catheter-associated bloodstream infections in children with cancer

July 27, 2015
Ethanol locks prevented central venous catheter-associated bloodstream infections in pediatric patients with cancer, according to the results of a randomized…
Harvoni shows promise for HCV genotype 4 In the Journals

Harvoni shows promise for HCV genotype 4

July 27, 2015
Phase 2a trial results suggest treatment with the combination regimen Harvoni yielded high rates of sustained virologic response and was well-tolerated in patients with…
More News Headlines »
CME
Infectious Disease Case Consults

The Patient at Risk for HIV Infection

No commercial support for this activity.

This CME activity will focus on the utilization of PrEP in patients at risk for developing HIV infection supplemented…
More »
At Issue Video
VIDEO: Cure is ‘next frontier’ of HIV

VIDEO: Cure is ‘next frontier’ of HIV

July 1, 2015
Timothy Brown – the Berlin patient – has led researchers to the next frontier of HIV research, according to…
More »
CME
Conjuctivitis

Management of Pediatric Conjunctivitis and Otitis/Conjunctivitis Syndrome

This activity is supported by an educational grant from Alcon Research, LTD.

Acute bacterial conjunctivitis affects approximately 1 of every 8 children each year, and 5 million cases occur in the…
More »
morganatic-roan